|
2020
|
Invention
|
Switchable chimeric antigen receptor-engineered human natural killer cells. Engineered natural ki... |
|
2018
|
Invention
|
Methods for inducing chondrogenesis. Described herein are compounds and compositions for the amel... |
|
2017
|
Invention
|
Methods and compositions for preventing vector-borne disease transmission. Disclosed herein are m... |
|
|
Invention
|
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimiz... |
|
|
Invention
|
Compositions and methods for treating drug-resistant bacteria. Disclosed herein are methods for t... |
|
|
Invention
|
Kv1.3 channel blocking peptides and uses thereof. Disclosed herein are Kv1.3 channel inhibitor pe... |
|
|
Invention
|
Humanized anti-cd3 antibodies, conjugates and uses thereof. The present invention provides for hu... |
|
2016
|
Invention
|
Elastase inhibitors.
Described herein are compounds, compositions, and methods of their use for ... |
|
|
Invention
|
Relaxin immunoglobulin fusion proteins and methods of use. Disclosed herein are relaxin immunoglo... |
|
|
Invention
|
Oxyntomodulin analogs and methods of making and using same. Provided are oxyntomodulin analogs. T... |
|
|
Invention
|
Insulin immunoglobulin fusion proteins. Disclosed herein are immunoglobulin fusion proteins compr... |
|
|
Invention
|
Composition and methods for inhibiting mammalian sterile 20-like kinase 1. Disclosed herein are c... |
|
|
Invention
|
Modified therapeutic agents and compositions thereof. Methods and compositions are provided for e... |
|
|
Invention
|
Optimized chimeric receptor t cell switches and uses thereof. Disclosed herein are switches for r... |
|
|
Invention
|
Chimeric receptor t cell switches for her2. Disclosed herein are switches for regulating the acti... |
|
|
Invention
|
Optimized pne-based chimeric receptor t cell switches and uses thereof. Disclosed herein are chim... |
|
|
Invention
|
Methods for treating viral infections. Described herein are methods for treating a viral infectio... |
|
|
Invention
|
Switchable non-scfv chimeric receptors, switches, and uses thereof. Disclosed herein are switchab... |
|
|
Invention
|
Methods of antibiotic treatment with metal-thiolate complexes. The present invention provides met... |
|
|
Invention
|
Antibody drug conjugates for the treatment of immune conditions. Disclosed herein are antibody ki... |
|
|
Invention
|
Compounds for treatment of cystic fibrosis. Described herein are compounds, compositions, and met... |
|
2015
|
Invention
|
Small molecule inhibitors of fibrosis. Described herein are compounds and compositions for the tr... |
|
|
Invention
|
Engineered cell surface proteins and uses thereof. Disclosed herein are engineered cell surface p... |
|
|
Invention
|
Elastase inhibitors. Described herein are compounds, compositions, and methods of their use for t... |
|
|
Invention
|
Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof. D... |
|
|
Invention
|
Constant region antibody fusion proteins and compositions thereof. Disclosed herein are antibody ... |
|
|
Invention
|
Lung localized inhibitors of alpha(v)beta 6. Described herein are compounds, compositions, and me... |
|
2014
|
Invention
|
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof. Methods ... |
|
|
Invention
|
Peptidic chimeric antigen receptor t cell switches and uses thereof. Disclosed herein are chimeri... |
|
|
Invention
|
Chimeric antigen receptor t cell switches and uses thereof. Disclosed herein are switches for reg... |
|
|
Invention
|
Coiled coil immunoglobulin fusion proteins and compositions thereof. Disclosed herein are immunog... |
|
|
Invention
|
Immunoglobulin fusion proteins and compositions thereof. Disclosed herein are immunoglobulin fusi... |
|
|
Invention
|
Compounds for treatment of drug resistant and persistent tuberculosis. Described herein are compo... |
|
|
Invention
|
Bispecific antibodies and uses thereof. Methods, compositions and uses are provided for bispecifi... |
|
|
Invention
|
Targeting agent antibody conjugates and uses thereof. Methods, compositions and uses are provided... |
|
|
Invention
|
Compounds and methods for inducing chondrogenesis. Described herein are compounds and composition... |
|
|
Invention
|
Bovine fusion antibodies. Disclosed herein are immunoglobulin constructs comprising at least one ... |
